XENOPSIN, NEUROTENSIN, NEUROTENSIN(8-13) AND N-ACETYL-NEUROTENSIN(8-13) INHIBIT VASCULAR LEAKAGE IN RATS AFTER TISSUE-INJURY

被引:0
|
作者
GAO, GC [1 ]
WEI, ET [1 ]
机构
[1] UNIV CALIF BERKELEY,SCH PUBL HLTH,BERKELEY,CA 94720
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Swelling, edema and leakage of proteins from the vascular compartment are immediate inflammatory responses of living tissues to local injury. Xenopsin, neurotensin (NT), NT(8-13) and NAcNT(8-13) administered to male rats anesthetized with sodium pentobarbital 60 mg/kg i.p. inhibited swelling and edema in the paw induced by immersion in 58-degrees-C water for 1 min. The ED50 values for xenopsin, NT, NAcNT(8-13) and NT(8-13) for reducing heat-induced edema were 0.9, 1.5, 1.9 and 2.1 nmol/kg i.v., respectively. NAcNT(8-13) was chosen as a prototype for further studies because, compared to NT, it had minimal hypotensive effects. NAcNT(8-13), 4 nmol/kg i.v., injected 10 min before mechanical injury to muscle, produced by a 4 cm midline surgical incision in the rectus abdominis, or before freeze injury to the cortex, produced by applying a cold probe (-50-degrees-C) to the skull for 4 min, reduced vascular leakage, measured as area of Monastral blue staining of the injured tissues. NAcNT(8-13), 4 nmol/kg i.v., also attenuated pulmonary edema induced by epinephrine bitartrate 10 mug/kg i.v. The ability of NAcNT(8-13) to inhibit vascular leakage was not linked to its transient hypotensive effects and it was not blocked by alpha-helical-CRF(9-41), a putative CRF receptor antagonist, or by chlorpheniramine, a H-1-histamine receptor antagonist.
引用
收藏
页码:619 / 625
页数:7
相关论文
共 50 条
  • [1] INHIBITION OF SUBSTANCE-P-INDUCED VASCULAR LEAKAGE IN RAT BY N-ACETYL-NEUROTENSIN-(8-13)
    GAO, GC
    WEI, ET
    REGULATORY PEPTIDES, 1995, 58 (03) : 117 - 121
  • [2] Development of nonpeptidic neurotensin (8-13) mimetics
    Hong, F
    Pang, YP
    Cusack, B
    Richelson, E
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 213 : 61 - MEDI
  • [3] Novel potent neurotensin (8-13) mimetics
    Hong, F
    Zaidi, J
    Cusack, B
    Richelson, E
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 215 : U903 - U903
  • [4] Fluorescent derivatives of bovine neurotensin 8-13 fragment
    Kele, P
    Illyés, E
    Mezö, G
    Dóda, M
    Mák, M
    Kaposi, AD
    Sebestyén, F
    LETTERS IN PEPTIDE SCIENCE, 1999, 6 (04): : 235 - 238
  • [5] Chemical stability of new neurotensin (8-13) analogues
    Michailova, S.
    Dzimbova, T.
    Kalikova, K.
    Tesarova, E.
    Pajpanova, T.
    BULGARIAN CHEMICAL COMMUNICATIONS, 2017, 49 : 113 - 117
  • [6] Docking studies of novel neurotensin(8-13) analogues
    Dzimbova, Tatyana
    Pajpanova, Tamara
    AMINO ACIDS, 2015, 47 (08) : 1688 - 1688
  • [7] Fluorescent derivatives of bovine neurotensin 8-13 fragment
    Kele P.
    Illyés E.
    Mezö G.
    Dóda M.
    Mák M.
    Kaposi A.D.
    Sebestyén F.
    Letters in Peptide Science, 1999, 6 (4): : 235 - 238
  • [8] Fluorescent derivatives of bovine neurotensin 8-13 fragment
    Kele P.
    Illyés E.
    Mezö G.
    Dóda M.
    Mák M.
    Kaposi A.D.
    Sebestyén F.
    Letters in Peptide Science, 1999, 6 (4): : 235 - 238
  • [9] METABOLICALLY STABLE ANALOGS OF NEUROTENSIN (8-13) WITH PSYCHOTROPIC ACTIVITY
    TSUCHIYA, Y
    SASAKI, A
    YOSHINO, H
    KARIBE, N
    SUGIMOTO, H
    KUBOTA, A
    KOSASA, M
    ARAKI, S
    UCHIKOSHI, K
    YAMANISHI, Y
    MACHIDA, R
    YAMATSU, K
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1990, 200 : 15 - MEDI
  • [10] SYNTHESIS AND PHARMACOLOGICAL EVALUATION OF NOVEL NEUROTENSIN(8-13) ANALOGUES
    Dzimbova, T.
    Stoeva, S.
    Tancheva, L.
    Georgieva, A.
    Kalfin, R.
    Pajpanova, T.
    JOURNAL OF PEPTIDE SCIENCE, 2014, 20 : S241 - S241